| 1 |
Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease |
|
| | Iram Hussain,Nivedita Patni,Abhimanyu Garg | | | Pathology. 2019; 51(2): 202 | | | [Pubmed] [Google Scholar] [DOI] | | | 2 |
Phenotypic diversity and glucocorticoid sensitivity in patients with familial partial lipodystrophy type 2 |
|
| | Ana Teresa Prata Resende,Clarissa Silva Martins,Ana Carolina Bueno,Ayrton Custódio Moreira,Maria Cristina Foss-Freitas,Margaret de Castro | | | Clinical Endocrinology. 2019; | | | [Pubmed] [Google Scholar] [DOI] | | | 3 |
Endoplasmic reticulum stress activation in adipose tissue induces metabolic syndrome in individuals with familial partial lipodystrophy of the Dunnigan type |
|
| | Maria C. Foss-Freitas,Rafael C. Ferraz,Luciana Z. Monteiro,Patricia M. Gomes,Ricardo Iwakura,Luiz Carlos C. de Freitas,Milton C. Foss | | | Diabetology & Metabolic Syndrome. 2018; 10(1) | | | [Pubmed] [Google Scholar] [DOI] | | | 4 |
Next-Generation Sequencing-Based Genetic Testing For Familial Partial Lipodystrophy |
|
| | Hesarghatta Shyamasunder Asha,Aaron Chapla,Shrinath Shetty,Nihal Thomas | | | AACE Clinical Case Reports. 2015; 1(1): e28 | | | [Pubmed] [Google Scholar] [DOI] | | | 5 |
Systematic analysis of diabetes- and glucose metabolism-related proteins and its application to Alzheimer’s disease |
|
| | Jie Yang,Sen Li,Yan-Xin Liu | | | Journal of Biomedical Science and Engineering. 2013; 06(06): 615 | | | [Pubmed] [Google Scholar] [DOI] | |
|
